Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Dolby Laboratories, Inc.
Report date December 15, 2017 · Filed December 20, 2017
Section 16 reporting ended · disclosed 2017-12-20. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 45,032 |
Reported balance
After 2017-12-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2017-12-15 · Tax withholding · Disposed 5,069 · Balance 45,032 F1: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. F2: Shares held following the reported transactions include 31,037 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. |
Filing footnotes · ownership attribution and instrument terms
F1: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units.
F2: Shares held following the reported transactions include 31,037 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 15, 2017 Filed Dec 20, 2017 01:51 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 5,069 | $60.99 | $309,158.31 |
DisclosureSEC source: 0001209191-17-066566 · doc4.xml · nonDerivative · entry 1 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,032 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. F2 · balance_after: Shares held following the reported transactions include 31,037 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| November 30, 2017 Filed Dec 1, 2017 02:34 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 48,361 | $0.00 Strike: $42.98 | $0.00 |
DisclosureSEC source: 0001209191-17-063134 · doc4.xml · derivative · entry 12 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,061 Underlying: Class A Common Stock · 48,361 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option was granted for a total of 85,146 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2014, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter. Read SEC document |
| November 30, 2017 Filed Dec 1, 2017 02:34 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 48,361 | $61.93 | $2,994,880.66 |
DisclosureSEC source: 0001209191-17-063134 · doc4.xml · nonDerivative · entry 8 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,101 F4 · price: This transaction was executed in multiple trades at prices ranging from $61.90 to $62.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 40,748 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| November 30, 2017 Filed Dec 1, 2017 02:34 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 48,361 | $42.98 | $2,078,555.78 |
DisclosureSEC source: 0001209191-17-063134 · doc4.xml · nonDerivative · entry 7 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,462 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 40,748 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| November 29, 2017 Filed Dec 1, 2017 02:34 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 13,724 | $0.00 Strike: $42.98 | $0.00 |
DisclosureSEC source: 0001209191-17-063134 · doc4.xml · derivative · entry 11 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,422 Underlying: Class A Common Stock · 13,724 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option was granted for a total of 85,146 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2014, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter. Read SEC document |
| November 29, 2017 Filed Dec 1, 2017 02:34 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 36,276 | $0.00 Strike: $41.31 | $0.00 |
DisclosureSEC source: 0001209191-17-063134 · doc4.xml · derivative · entry 10 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,128 Underlying: Class A Common Stock · 36,276 shares Expires 2024-01-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option was granted for a total of 219,050 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of January 15, 2014, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter. Read SEC document |
| November 29, 2017 Filed Dec 1, 2017 02:34 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 13,724 | $61.81 | $848,290.05 |
DisclosureSEC source: 0001209191-17-063134 · doc4.xml · nonDerivative · entry 6 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,101 F3 · price: This transaction was executed in multiple trades at prices ranging from $61.75 to $61.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 40,748 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| November 29, 2017 Filed Dec 1, 2017 02:34 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 13,724 | $42.98 | $589,857.52 |
DisclosureSEC source: 0001209191-17-063134 · doc4.xml · nonDerivative · entry 5 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,825 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 40,748 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| November 29, 2017 Filed Dec 1, 2017 02:34 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 36,276 | $61.81 | $2,242,244.95 |
DisclosureSEC source: 0001209191-17-063134 · doc4.xml · nonDerivative · entry 4 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,101 F3 · price: This transaction was executed in multiple trades at prices ranging from $61.75 to $61.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 40,748 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| November 29, 2017 Filed Dec 1, 2017 02:34 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 36,276 | $41.31 | $1,498,561.56 |
DisclosureSEC source: 0001209191-17-063134 · doc4.xml · nonDerivative · entry 3 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,377 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 40,748 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| November 28, 2017 Filed Dec 1, 2017 02:34 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $41.31 | $0.00 |
DisclosureSEC source: 0001209191-17-063134 · doc4.xml · derivative · entry 9 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,404 Underlying: Class A Common Stock · 50,000 shares Expires 2024-01-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option was granted for a total of 219,050 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of January 15, 2014, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter. Read SEC document |
| November 28, 2017 Filed Dec 1, 2017 02:34 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 50,000 | $62.72 | $3,135,840.00 |
DisclosureSEC source: 0001209191-17-063134 · doc4.xml · nonDerivative · entry 2 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,101 F2 · price: This transaction was executed in multiple trades at prices ranging from $62.55 to $62.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 40,748 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| November 28, 2017 Filed Dec 1, 2017 02:34 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 50,000 | $41.31 | $2,065,500.00 |
DisclosureSEC source: 0001209191-17-063134 · doc4.xml · nonDerivative · entry 1 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,101 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 40,748 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| November 20, 2017 Filed Nov 22, 2017 01:21 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 33,179 | $0.00 Strike: $41.31 | $0.00 |
DisclosureSEC source: 0001288257-17-000015 · primary_doc.xml · derivative · entry 3 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,404 Underlying: Class A Common Stock · 33,179 shares Expires 2024-01-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option was granted for a total of 171,425 shares of Class A Common Stock. 1/4th of the total number of shares issuable under the option vested on the first anniversary of January 15, 2014, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter. Read SEC document |
| November 20, 2017 Filed Nov 22, 2017 01:21 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 33,179 | $61.74 | $2,048,315.52 |
DisclosureSEC source: 0001288257-17-000015 · primary_doc.xml · nonDerivative · entry 2 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,101 F2 · price: This transaction was executed in multiple trades at prices ranging from $61.65 to $61.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 40,748 restricted stock units which are subject to forfeiture until they vest. Read SEC document |
| November 20, 2017 Filed Nov 22, 2017 01:21 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 33,179 | $41.31 | $1,370,624.49 |
DisclosureSEC source: 0001288257-17-000015 · primary_doc.xml · nonDerivative · entry 1 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,280 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 40,748 restricted stock units which are subject to forfeiture until they vest. Read SEC document |
| November 17, 2017 Filed Nov 18, 2017 02:24 UTC Amendment | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $41.31 | $0.00 |
DisclosureSEC source: 0001209191-17-061666 · doc4a.xml · derivative · entry 12 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,583 Underlying: Class A Common Stock · 50,000 shares Expires 2014-01-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This option was granted for a total of 171,425 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of January 15, 2014, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter. Read SEC document |
| November 17, 2017 Filed Nov 18, 2017 02:24 UTC Amendment | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 50,000 | $61.32 | $3,066,175.00 |
DisclosureSEC source: 0001209191-17-061666 · doc4a.xml · nonDerivative · entry 8 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,101 F5 · price: This transaction was executed in multiple trades at prices ranging from $61.31 to $61.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 40,748 restricted stock units, which are subject to forfeiture until they vest. F2 · balance_after: Shares include 526 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2017. Read SEC document |
| November 17, 2017 Filed Nov 18, 2017 02:24 UTC Amendment | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 50,000 | $41.31 | $2,065,500.00 |
DisclosureSEC source: 0001209191-17-061666 · doc4a.xml · nonDerivative · entry 7 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,101 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 40,748 restricted stock units, which are subject to forfeiture until they vest. F2 · balance_after: Shares include 526 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2017. Read SEC document |
| November 17, 2017 Filed Nov 18, 2017 00:37 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $41.31 | $0.00 |
DisclosureSEC source: 0001209191-17-061655 · doc4.xml · derivative · entry 12 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,583 Underlying: Class A Common Stock · 50,000 shares Expires 2014-01-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This option was granted for a total of 171,425 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of January 15, 2014, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter. Read SEC document |
| November 17, 2017 Filed Nov 18, 2017 00:37 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 50,000 | $61.32 | $3,066,175.00 |
DisclosureSEC source: 0001209191-17-061655 · doc4.xml · nonDerivative · entry 8 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,101 F5 · price: This transaction was executed in multiple trades at prices ranging from $61.31 to $61.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 40,748 restricted stock units, which are subject to forfeiture until they vest. F2 · balance_after: Shares include 526 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2017. Read SEC document |
| November 17, 2017 Filed Nov 18, 2017 00:37 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 50,000 | $41.31 | $2,065,500.00 |
DisclosureSEC source: 0001209191-17-061655 · doc4.xml · nonDerivative · entry 7 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,101 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 40,748 restricted stock units, which are subject to forfeiture until they vest. F2 · balance_after: Shares include 526 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2017. Read SEC document |
| November 16, 2017 Filed Nov 18, 2017 02:24 UTC Amendment | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 16,821 | $0.00 Strike: $41.31 | $0.00 |
DisclosureSEC source: 0001209191-17-061666 · doc4a.xml · derivative · entry 11 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,583 Underlying: Class A Common Stock · 16,821 shares Expires 2024-01-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This option was granted for a total of 171,425 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of January 15, 2014, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter. Read SEC document |
| November 16, 2017 Filed Nov 18, 2017 02:24 UTC Amendment | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 16,821 | $61.09 | $1,027,601.62 |
DisclosureSEC source: 0001209191-17-061666 · doc4a.xml · nonDerivative · entry 6 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,101 F4 · price: This transaction was executed in multiple trades at prices ranging from $61 to $61.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 40,748 restricted stock units, which are subject to forfeiture until they vest. F2 · balance_after: Shares include 526 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2017. Read SEC document |
| November 16, 2017 Filed Nov 18, 2017 02:24 UTC Amendment | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 16,821 | $41.31 | $694,875.51 |
DisclosureSEC source: 0001209191-17-061666 · doc4a.xml · nonDerivative · entry 5 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,922 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 40,748 restricted stock units, which are subject to forfeiture until they vest. F2 · balance_after: Shares include 526 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2017. Read SEC document |
| November 16, 2017 Filed Nov 18, 2017 00:37 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 16,821 | $0.00 Strike: $41.31 | $0.00 |
DisclosureSEC source: 0001209191-17-061655 · doc4.xml · derivative · entry 11 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,583 Underlying: Class A Common Stock · 16,821 shares Expires 2024-01-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This option was granted for a total of 171,425 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of January 15, 2014, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter. Read SEC document |
| November 16, 2017 Filed Nov 18, 2017 00:37 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 16,821 | $61.09 | $1,027,601.62 |
DisclosureSEC source: 0001209191-17-061655 · doc4.xml · nonDerivative · entry 6 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,101 F4 · price: This transaction was executed in multiple trades at prices ranging from $61 to $61.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 40,748 restricted stock units, which are subject to forfeiture until they vest. F2 · balance_after: Shares include 526 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2017. Read SEC document |
| November 16, 2017 Filed Nov 18, 2017 00:37 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 16,821 | $41.31 | $694,875.51 |
DisclosureSEC source: 0001209191-17-061655 · doc4.xml · nonDerivative · entry 5 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,922 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 40,748 restricted stock units, which are subject to forfeiture until they vest. F2 · balance_after: Shares include 526 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2017. Read SEC document |
| November 15, 2017 Filed Nov 18, 2017 02:24 UTC Amendment | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 23,646 | $0.00 Strike: $41.31 | $0.00 |
DisclosureSEC source: 0001209191-17-061666 · doc4a.xml · derivative · entry 10 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,404 Underlying: Class A Common Stock · 23,646 shares Expires 2024-01-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This option was granted for a total of 171,425 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of January 15, 2014, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter. Read SEC document |
| November 15, 2017 Filed Nov 18, 2017 02:24 UTC Amendment | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 26,354 | $0.00 Strike: $33.15 | $0.00 |
DisclosureSEC source: 0001209191-17-061666 · doc4a.xml · derivative · entry 9 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,646 Underlying: Class A Common Stock · 26,354 shares Expires 2025-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option was granted for a total of 55,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2015, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter. Read SEC document |
| November 15, 2017 Filed Nov 18, 2017 02:24 UTC Amendment | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 23,646 | $61.00 | $1,442,465.12 |
DisclosureSEC source: 0001209191-17-061666 · doc4a.xml · nonDerivative · entry 4 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,101 F3 · price: This transaction was executed in multiple trades at prices ranging from $61 to $61.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 40,748 restricted stock units, which are subject to forfeiture until they vest. F2 · balance_after: Shares include 526 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2017. Read SEC document |
| November 15, 2017 Filed Nov 18, 2017 02:24 UTC Amendment | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 23,646 | $41.31 | $976,816.26 |
DisclosureSEC source: 0001209191-17-061666 · doc4a.xml · nonDerivative · entry 3 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,747 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 40,748 restricted stock units, which are subject to forfeiture until they vest. F2 · balance_after: Shares include 526 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2017. Read SEC document |
| November 15, 2017 Filed Nov 18, 2017 02:24 UTC Amendment | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 26,354 | $61.00 | $1,607,659.89 |
DisclosureSEC source: 0001209191-17-061666 · doc4a.xml · nonDerivative · entry 2 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,101 F3 · price: This transaction was executed in multiple trades at prices ranging from $61 to $61.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 40,748 restricted stock units, which are subject to forfeiture until they vest. F2 · balance_after: Shares include 526 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2017. Read SEC document |
| November 15, 2017 Filed Nov 18, 2017 02:24 UTC Amendment | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 26,354 | $33.15 | $873,635.10 |
DisclosureSEC source: 0001209191-17-061666 · doc4a.xml · nonDerivative · entry 1 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 40,748 restricted stock units, which are subject to forfeiture until they vest. F2 · balance_after: Shares include 526 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2017. Read SEC document |
| November 15, 2017 Filed Nov 18, 2017 00:37 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 23,646 | $0.00 Strike: $41.31 | $0.00 |
DisclosureSEC source: 0001209191-17-061655 · doc4.xml · derivative · entry 10 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,404 Underlying: Class A Common Stock · 23,646 shares Expires 2024-01-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This option was granted for a total of 171,425 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of January 15, 2014, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter. Read SEC document |
| November 15, 2017 Filed Nov 18, 2017 00:37 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 26,354 | $0.00 Strike: $33.15 | $0.00 |
DisclosureSEC source: 0001209191-17-061655 · doc4.xml · derivative · entry 9 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,646 Underlying: Class A Common Stock · 26,354 shares Expires 2025-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option was granted for a total of 55,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2015, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter. Read SEC document |
| November 15, 2017 Filed Nov 18, 2017 00:37 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 23,646 | $61.00 | $1,442,465.12 |
DisclosureSEC source: 0001209191-17-061655 · doc4.xml · nonDerivative · entry 4 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,101 F3 · price: This transaction was executed in multiple trades at prices ranging from $61 to $61.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 40,748 restricted stock units, which are subject to forfeiture until they vest. F2 · balance_after: Shares include 526 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2017. Read SEC document |
| November 15, 2017 Filed Nov 18, 2017 00:37 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 23,646 | $41.31 | $976,816.26 |
DisclosureSEC source: 0001209191-17-061655 · doc4.xml · nonDerivative · entry 3 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,747 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 40,748 restricted stock units, which are subject to forfeiture until they vest. F2 · balance_after: Shares include 526 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2017. Read SEC document |
| November 15, 2017 Filed Nov 18, 2017 00:37 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 26,354 | $61.00 | $1,607,659.89 |
DisclosureSEC source: 0001209191-17-061655 · doc4.xml · nonDerivative · entry 2 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,101 F3 · price: This transaction was executed in multiple trades at prices ranging from $61 to $61.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 40,748 restricted stock units, which are subject to forfeiture until they vest. F2 · balance_after: Shares include 526 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2017. Read SEC document |
| November 15, 2017 Filed Nov 18, 2017 00:37 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 26,354 | $33.15 | $873,635.10 |
DisclosureSEC source: 0001209191-17-061655 · doc4.xml · nonDerivative · entry 1 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 40,748 restricted stock units, which are subject to forfeiture until they vest. F2 · balance_after: Shares include 526 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2017. Read SEC document |
| May 12, 2017 Filed May 16, 2017 21:22 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GiftClass A Common Stock | 1,555 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-032809 · doc4.xml · nonDerivative · entry 2 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,575 F3 · kind: Gift to a charitable and/or non-profit organization. F2 · balance_after: Shares held following the reported transactions include 40,748 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| May 12, 2017 Filed May 16, 2017 21:22 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 11,666 | $51.38 | $599,350.08 |
DisclosureSEC source: 0001209191-17-032809 · doc4.xml · nonDerivative · entry 1 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,130 F1 · price: This transaction was executed in multiple trades at prices ranging from $51.33 to $51.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares held following the reported transactions include 40,748 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| January 15, 2017 Filed Jan 19, 2017 22:08 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 4,666 | $48.94 | $228,354.04 |
DisclosureSEC source: 0001209191-17-004578 · doc4.xml · nonDerivative · entry 1 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,796 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incident to the vesting of restricted stock units. F2 · balance_after: Shares held following the reported transactions include 40,748 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2016 Filed Dec 20, 2016 00:10 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantEmployee Stock Option (Right to Buy) · Derivative | 46,000 | $0.00 Strike: $45.50 | $0.00 |
DisclosureSEC source: 0001209191-16-156009 · doc4.xml · derivative · entry 4 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,000 Underlying: Class A Common Stock · 46,000 shares Expires 2026-12-15 F7 · derivative.exercise_date: This option was granted for a total of 46,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2016, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter. Read SEC document |
| December 15, 2016 Filed Dec 20, 2016 00:10 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantPerformance-Based Stock Option (Right to Buy) · Derivative | 23,000 | $0.00 Strike: $45.50 | $0.00 |
DisclosureSEC source: 0001209191-16-156009 · doc4.xml · derivative · entry 3 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,000 Underlying: Class A Common Stock · 23,000 shares Expires 2023-12-15 F6 · derivative.exercise_date: The vesting of this performance-based stock option ("PSO") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2016 and ending December 15, 2019. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 125% of the target award amount based on total shareholder return at the end of the three-year performance period. The actual PSO award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. Read SEC document |
| December 15, 2016 Filed Dec 20, 2016 00:10 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 2,569 | $45.50 | $116,889.50 |
DisclosureSEC source: 0001209191-16-156009 · doc4.xml · nonDerivative · entry 2 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,462 F4 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incident to the vesting of restricted stock units. F5 · balance_after: Shares held following the reported transactions include 52,886 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2016 Filed Dec 20, 2016 00:10 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 11,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-156009 · doc4.xml · nonDerivative · entry 1 Borchers Bob · CIK 0001596051 · SVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,031 F1 · acquired: Award represents a total of 11,500 restricted stock units granted under the terms of the Issuer's 2005 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 15, 2016. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. F2 · balance_after: Shares held following the reported transactions include 59,721 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. F3 · balance_after: Shares include 10 shares acquired under the Issuer's Employee Stock Purchase Plan on November 15, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.